Want to know more about point of care testing (POCT)? Look no further! We’ve pulled together all the must-have resources for you to stay in the know about the latest developments and techniques in point of care testing.
Read on to explore a collection of videos, articles, webinars, and more to supplement your knowledge of point of care testing. Topics of interest include cardiac troponin assays for acute coronary syndrome (ACS), natriuretic peptide testing for the diagnosis of heart failure, and point of care blood gas analysis.
High-sensitivity cardiac troponin (hs-cTn) assays are used in the evaluation of patients with suspected ACS in the emergency department (ED). While these tests are typically laboratory-based, new technology is now enabling their use at the point of care. Dr. Martin Than, Director of Emergency Medicine Research, Christchurch Hospital, New Zealand, discusses the impact that a point of care hs-cTn assay would have on the ED, the key factors that would need to be considered when introducing this test, as well as its potential impact beyond the ED.
Dr. Michael Samoszuk, Medical Officer at Siemens Healthineers, discusses the analytical performance of point of care hs-cTn assays. Hear how they compare to laboratory-based tests, when they are most useful, and the importance of gender-specific reference ranges.
Dr. Rick Body, Professor of Emergency Medicine at the University of Manchester and Honorary Consultant in Emergency Medicine and Group Director of Research & Innovation at Manchester University NHS Foundation Trust, discusses the impact that point of care hs-cTn testing could have on the management of patients with suspected myocardial infarction.
In this video interview, Prof. Damien Gruson, Head of the Department of Clinical Biochemistry, Cliniques Universitaires Saint-Luc, details key considerations for healthcare providers looking to transition to point of care hs-cTn immunoassays in the ED.
In this panel debate, Dr. Frank Peacock, Dr. Louise Cullen, and Dr. Rick Body explore the value of high-sensitivity troponin in the assessment of patients with suspected ACS. This webinar covers the utilization of hs-cTn in the ED and its impact when delivered via a rapid point of care device or core laboratory.
This exclusive article provides insights into how EDs are reducing turnaround time with POCT. Read now to explore innovative POC technology that’s being used to meet today’s emergency care needs and inform effective management of cardiac patients.
In this exclusive interview, Dr. Michael Samoszuk further discusses the benefits of hs-cTn point of care assays and shares his views on how they will be positioned in future healthcare settings.
ED overcrowding is a global issue that has been linked to negative consequences for patient care and outcomes. In this expert interview, Dr. Martin Than shares how the adoption of POC assays could enable rapid decision making, to help tackle overcrowding issues in emergency settings.
Heart failure is a common diagnosis caused by different forms of heart disease. In this video, Dr. James Januzzi, Hutter Family Professor of Medicine at Harvard Medical School and Cardiologist at Massachusetts General Hospital, discusses the role of natriuretic peptides – BNP and NT-proBNP – as biomarkers for the evaluation of acute and chronic heart failure.
Dr. Lori Daniels, Medical Director of the Cardiovascular Intensive Care Unit at UC San Diego Health, discusses how a fingerstick point of care natriuretic peptide test will bring value to the ED, as well as inpatient and outpatient settings, and what impact this will have on patient care.
In this video, Ken Kohut, mobile integrated health program specialist at Niagara Emergency Medical Services, explains how POCT performed in patients’ own homes provides quantitative results that enable appropriate treatment decisions.
Patti DeJuilio, clinical director of respiratory care services and Northwestern Medicine Central DuPage Hospital’s sleep center, shares Hear about one hospital department’s transition to point of care blood gas testing and the impact it has had during the COVID-19 pandemic.
Watch this webinar for further insights into the implementation of POCT and its impact on cost, sepsis bundle compliance, and employee engagement. Specifically, the increased utilization of lactate testing with improved sepsis bundle compliance and improvements associated with clinical, operational, and financial outcomes are addressed.
Take a look at what other clinical professionals all over the world are saying about the latest equipment and technologies driving POCT. Here, Mariano Martinez, Hospital Vall D'Hebron, shares his opinion on the epoc® Blood Analysis System by Siemens Healthineers.